Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • BFSI
      • Capital Goods
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Health»Renowned Cardiologist Dr Luca Testa Highlights the Effectiveness of Abluminus DES+ in Complex Angioplasty Cases
    Health

    Renowned Cardiologist Dr Luca Testa Highlights the Effectiveness of Abluminus DES+ in Complex Angioplasty Cases

    By July 10, 2023No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Faridabad/Aligarh [India], July 10: Dr Luca Testa, a renowned interventional cardiologist at IRCCS Policlinico San Donato – Milan, Italy, has successfully conducted a series of educational workshops on the effectiveness of Abluminus DES+ in complex percutaneous coronary intervention. These workshops, organized by Concept Medical as part of their educational initiative, showcased the superior capabilities of Abluminus DES+ in treating complex lesions and diffuse disease in angioplasty.

    The first workshop was held on 3rd July 2023 at Jawaharlal Nehru Medical College and Hospital (Aligarh Muslim University) in collaboration with Dr Asif Hasan and Dr Azharuddin Malik. The second workshop took place on 4th July 2023 at Fortis Escorts Hospital, Faridabad, with the participation of Dr Sanjay Kumar alongside Dr. Luca Testa.

    Dr. Luca Testa expressed his satisfaction with the outcomes achieved using Abluminus DES+ in all the workshops conducted in various Indian institutions. The cases involved patients with complex coronary disease, including chronic total occlusions (CTOs) and severe in-stent restenosis.

    “Abluminus DES+ has been my choice of stent for many years, particularly in complex cases, and the results have been promising,” stated Dr. Luca Testa during a press conference. “This unique combination of a drug-coated balloon and a bioresorbable polymer sirolimus-eluting stent offers distinct advantages, especially when treating complex and diffuse disease. It is noteworthy that interventional cardiology is undergoing a significant paradigm shift. Despite the availability of advanced DES technologies like Abluminus DES+, we are progressively changing our approach, considering alternative options such as the Sirolimus-coated balloon Magic Touch. I firmly believe that in the future, we will witness a further implementation of drug-coated balloon technology in our daily practice, either alongside or even independently of stent usage. Abluminus is undoubtedly one of the finest technologies available, especially for complex cases.”

    Dr. Luca Testa’s workshops have provided valuable insights into the efficacy and potential of Abluminus DES+ in complex angioplasty procedures. With these educational initiatives, Concept Medical and Dr Testa aim to enhance the knowledge and expertise of healthcare professionals in India, ultimately leading to improved patient outcomes and advancing the field of interventional cardiology.

    Explaining the innovation, Concept Medical’s Founder & MD, Dr Manish Doshi, said, “In several patients with type II diabetes and coronary heart disease, there is as recurrence of major adverse cardiac events (MACE) like heart attack, stroke and restenosis (narrowing of unblocked artery after operation). This abluminal drug-eluting stent DES+ will considerably reduce the chances of recurrence.”

    About Dr. Luca Testa:

    Dr. Luca Testa is a renowned interventional cardiologist at IRCCS Policlinico San Donato – Milan, Italy. With extensive experience in complex coronary interventions, Dr. Testa has been instrumental in the development and advancement of novel treatment options in the field of interventional cardiology.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    How Oncare Is Building a More Transparent & Affordable Model for Cancer Treatment in India

    September 17, 2026

    A First in India: Dermatologist Dr. Jagdish Sakhiya Launches Exclusive Facial Kit Formulated for Indian Skin

    September 10, 2026

    Six Generations of Medical Legacy Drive Sarkar Superspeciality Hospital’s Expansion in Agra

    September 9, 2026

    Comments are closed.

    Recent Post
    • The Omega Heist Author Madhav Das Meets Legendary Indian Actor Amitabh Bachchan
    • IMS UCC Ghaziabad Welcomes Freshers with an Inspiring Orientation Day, Marking the Beginning of a New Academic Journey
    • New Girls’ Hostel–1 Inaugurated at RGIPT Sivasagar Campus
    • Raincheck Earth Appoints Prashant Singh as Head of International Business
    • Celewish Media Introduces Maira Vardhan As Its AI Virtual CMO, Bringing AI-Led Thinking To Celebrity & Influencer Marketing
    • Hazoor Multi Projects Secures Rs 207 Crore Work Order for Chennai Residential Project
    • Sarvajanik University Hosts Youth Conclave on Climate Resilience and Sustainable City
    • UK bamboo sock brand Bare Kind forays into India with House of Kraft

    Type above and press Enter to search. Press Esc to cancel.